Forty sera of patients infected with Leishmania donovani and (10) sera from apparently healthy subject were tested by single radial immunodiffusion to visualize the concentration of IgG, IgM, IgA, C3 and C4. Recent results showed that there was a highly significant increase in the level of IgG, IgM, C3 and C4 but there were no significant differences in the level of IgA between the two—studied groups.

Leishmania donovani, amastigotes from dog marrow macrophages, ultrastructure

Leishmaniasis is a vector-borne zoonotic disease that is common in the world. Because of the difficulties in the treatment and control of the disease, the disease has gained popularity among researchers. Today, however, no vaccine has been developed for human protection. Considering the fact that the vector can survive in a wide ecosystem and the disease can be detected in many mammals such as humans, dogs, rodents, prevention from leishmaniasis and treatment of the disease require a combined intervention. The toxic effects of the drugs used in the treatment of leishmaniasis, the expensive treatment and the resistance of the parasite to the drug have led to the research of alternative treatment methods. This review is intended to provide an overview of leishmaniasis alternative treatment practices and to guide new researchs.

Blood glycated hemoglobin concentration reflects long-term serum glucose levels in dogs. In this study, the effects of several diseases on blood glycated hemoglobin levels have been evaluated. For this study, blood samples were drawn from 93 unhealthy dogs. The animals were distributed into 10 groups according to pathological process (group 1, digestive problems; group 2, leishmaniasis; group 3, anemia; group 4, dermatological disorders; group 5, urinary problems; group 6, cardiorespiratory problems; group 7, diabetes mellitus; group 8, insulinoma; group 9, general diseases; group 10, control group). Blood glucose and glycated hemoglobin concentrations and hemoglobin and hematocrit values were analyzed in all the animals. In diabetic dogs, a strong increase in blood glycated hemoglobin was observed when compared with the other groups (P < 0.01). In contrast, dogs with insulinoma showed a decrease in blood glycated hemoglobin, though significant differences were not reported in all cases. No change in blood glycated hemoglobin concentrations were reported in dogs affected by other diseases. So, we can suppose that only the chronic alterations in glucose metabolism (chronic hyper- or hypoglycemia) can induce significant changes on the blood glycated hemoglobin concentrations in dogs.

Leishmania donovani, dogs (exper.), liposome-encapsulated meglumine antimoniate (LEMA) vs. unencapsulated meglumine antimoniate, LEMA was 700 times more efficacious than the encapsulated drug, liposomes can markedly reduce the drug dosage required for equivalent treatment of visceral leishmaniasis

Leishmaniasis is a zoonotic disease which has worldwide importance and is hard to control and treat. Researchers have not yet developed a protective vaccine for humans in the light of current studies. Various experimental animal models are being used since; i) Leishmania has different species and vectors, ii) there are still many clinical, pathological and immunological issues that have to be investigated, iii) new non-toxic medical recipes to have maximum yield in a short time have to be investigated, iv) protective vaccination have to be developed. Mouse, hamster, dog, rodent, and non-human primates are among these animal models. None of them has the same clinical features, pathogenesis and immunology with the disease in human. However, rodents, dogs, and monkeys, which are the last host of the parasite, are among the most preferred models in recent days. Considering the different clinical forms of the disease, it is best to decide which Leishmania species to work with which animal. This review is intended to guide the researchers in choosing an appropriate animal model for leishmaniasis studies.